Brian Rosa
liked
NVIDIA Corporation ( $NVIDIA (NVDA.US)$) has reported its financial results for the fourth quarter of fiscal year 2025, showcasing robust performance driven by strong demand in the artificial intelligence (AI) sector.
Key Financial Highlights:
• Record Revenue: The company achieved a record quarterly revenue of $39.3 billion, marking a 78% increase from the same period last year and a 12% rise from the previous quarter.
• Data Center Growth: NVIDIA’s Data...
Key Financial Highlights:
• Record Revenue: The company achieved a record quarterly revenue of $39.3 billion, marking a 78% increase from the same period last year and a 12% rise from the previous quarter.
• Data Center Growth: NVIDIA’s Data...



31
Brian Rosa
liked
Current Situation:
NVIDIA’s stock ( $NVIDIA (NVDA.US)$) has shown recent weakness, trading lower as it approaches the earnings report on Feb 26, 2025. RSI currently sits between 39-45, indicating near oversold conditions. MACD remains bearish but suggests potential upside on positive surprises. Increased put options indicate investor caution, though some traders anticipate a bullish rebound through call options.
Potential Scenarios Post-Earnin...
NVIDIA’s stock ( $NVIDIA (NVDA.US)$) has shown recent weakness, trading lower as it approaches the earnings report on Feb 26, 2025. RSI currently sits between 39-45, indicating near oversold conditions. MACD remains bearish but suggests potential upside on positive surprises. Increased put options indicate investor caution, though some traders anticipate a bullish rebound through call options.
Potential Scenarios Post-Earnin...



+2
24
2
Brian Rosa
liked
$FTSE Bursa Malaysia KLCI Index (.KLSE.MY)$ took another hit and retraced back towards the 1568 points region with an overall bearish market sentiment as we saw over 900 counters closing red for the day here. Daily trading volume remains around the 3.1 billion mark, mainly dominated by sellers as foreign funds continue their selling spree.
Sad to say, there are no stocks on the top volumes list that performed well today as the widespread sell off con...
Sad to say, there are no stocks on the top volumes list that performed well today as the widespread sell off con...
18
1
1
Brian Rosa
liked
Super Pharma's 1H25 performance was below expectations, causing the stock price to drop accordingly.
Super Pharma's 1H25 performance was below expectations, causing the stock price to drop accordingly.
Yesterday, Super Pharma announced its performance. $SUPERMX (7106.MY)$ In the second quarter of the fiscal year 2025, losses significantly narrowed, with a loss of 4.92 million Ringgit, far lower than the 44.36 million Ringgit loss in the same period last year.
As of the end of December, the company's revenue grew by 36.57% year-on-year, reaching 0.1 billion 98.78 million Ringgit.
However, looking at the first half of the year, Supama accumulated a net loss of 69.55 million Ringgit, which has worsened compared to the net loss of 46.41 million Ringgit in the same period last year; the turnover recorded a total of 0.4 billion 23.44 million Ringgit, an increase of 30.9% year-on-year.
Analysts at the firm pointed out that this significantly falls short compared to their positive profit forecast (46.5 million Ringgit) and the market (28.7 million Ringgit).
This is mainly due to sales volumes being lower than expected, along with operating costs being higher than anticipated.
Furthermore, for the first half of 2025 (i.e., the second half of Supama's fiscal year 2025), analysts expect to still face competitive pressure from Chinese glove manufacturers, primarily because USA customers have increased their inventory before the tariff implementation, coupled with Chinese glove manufacturers actively capturing non-USA markets, which is expected to impact declining sales.
Currently, the price difference between Malaysia and China for gloves is about 2 USD per thousand pieces, while the global oversupply situation is expected to continue.
Dah Securities expects the company's sales to decline from 2025 to 2027, with respective adjustments of 5.0%, 13.8%, and 12.6%.
Yesterday, Super Pharma announced its performance. $SUPERMX (7106.MY)$ In the second quarter of the fiscal year 2025, losses significantly narrowed, with a loss of 4.92 million Ringgit, far lower than the 44.36 million Ringgit loss in the same period last year.
As of the end of December, the company's revenue grew by 36.57% year-on-year, reaching 0.1 billion 98.78 million Ringgit.
However, looking at the first half of the year, Supama accumulated a net loss of 69.55 million Ringgit, which has worsened compared to the net loss of 46.41 million Ringgit in the same period last year; the turnover recorded a total of 0.4 billion 23.44 million Ringgit, an increase of 30.9% year-on-year.
Analysts at the firm pointed out that this significantly falls short compared to their positive profit forecast (46.5 million Ringgit) and the market (28.7 million Ringgit).
This is mainly due to sales volumes being lower than expected, along with operating costs being higher than anticipated.
Furthermore, for the first half of 2025 (i.e., the second half of Supama's fiscal year 2025), analysts expect to still face competitive pressure from Chinese glove manufacturers, primarily because USA customers have increased their inventory before the tariff implementation, coupled with Chinese glove manufacturers actively capturing non-USA markets, which is expected to impact declining sales.
Currently, the price difference between Malaysia and China for gloves is about 2 USD per thousand pieces, while the global oversupply situation is expected to continue.
Dah Securities expects the company's sales to decline from 2025 to 2027, with respective adjustments of 5.0%, 13.8%, and 12.6%.
Translated

20
1
2
Brian Rosa
liked
$AMC Entertainment (AMC.US)$ is expected to post its quarterly earnings on 25 Feb 2025 after market closes.
It is expected to post a loss of $0.18 per share for the current quarter, representing a year-over-year change of +70.4%.
AMC Entertainment (AMC) Last Positive Earnings Call Saw A 25.11% Negative Change
AMC has a positive earnings call on 06 Nov 2024 but we saw AMC share price suffered a 25.11% change since, the earn...
It is expected to post a loss of $0.18 per share for the current quarter, representing a year-over-year change of +70.4%.
AMC Entertainment (AMC) Last Positive Earnings Call Saw A 25.11% Negative Change
AMC has a positive earnings call on 06 Nov 2024 but we saw AMC share price suffered a 25.11% change since, the earn...



+1
23
Brian Rosa
liked
$SUNCON-C19 (AMBANK (M) BERHAD) (526319.MY)$
Update
First TP hit at MYR 0.08. Wonder if it will hit 2nd TP today? ^_^
Update
First TP hit at MYR 0.08. Wonder if it will hit 2nd TP today? ^_^

26
4
Brian Rosa
liked
Brian Rosa
liked
Global markets
DJ +0.16% , S&P500 +0.24% , Nasdaq +0.07%
S&P500 hit another all-time high, shrugging off Fed guidance on January minutes. Markets opened lower after Trump hinted that the US may impose tariffs on automobiles, medicines and semiconductors. Then, S&P500 recouped loss and rebounded to finish at a new record close.
US treasury yields 10-year @ 4.54% ( -0.01 )
Bond futures market expects a full 0.25% ...
DJ +0.16% , S&P500 +0.24% , Nasdaq +0.07%
S&P500 hit another all-time high, shrugging off Fed guidance on January minutes. Markets opened lower after Trump hinted that the US may impose tariffs on automobiles, medicines and semiconductors. Then, S&P500 recouped loss and rebounded to finish at a new record close.
US treasury yields 10-year @ 4.54% ( -0.01 )
Bond futures market expects a full 0.25% ...



22
Brian Rosa
liked
It has started for the SureBet! DGLY
$Digital Ally (DGLY.US)$
Pain staking searches will always produce results. Patience is a virtue. Combining both makes for powerful decision-making
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Lo...
$Digital Ally (DGLY.US)$
Pain staking searches will always produce results. Patience is a virtue. Combining both makes for powerful decision-making
1. My strategy is to find an item that has immediate results in order to sell and recuperate the initial investment by selling 50% of the initial shares purchased. (SureBet!)
2. Leaving the remaining 50% to hit as a limit sale at the obnoxious goal minus 20% for a safer bet. (Lo...


11
2